UBS Group’s Neos Therapeutics, Inc NEOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-11,916
| Closed | -$7K | – | 8562 |
|
|
2020
Q4 | $7K | Buy |
+11,916
| New | +$7K | ﹤0.01% | 6708 |
|
|
2020
Q3 | – | Sell |
-26,555
| Closed | -$18K | – | 7642 |
|
|
2020
Q2 | $18K | Buy |
26,555
+18,839
| +244% | +$12.8K | ﹤0.01% | 5793 |
|
|
2020
Q1 | $6K | Buy |
7,716
+2,669
| +53% | +$2.08K | ﹤0.01% | 6341 |
|
|
2019
Q4 | $8K | Buy |
5,047
+3,045
| +152% | +$4.83K | ﹤0.01% | 6341 |
|
|
2019
Q3 | $3K | Buy |
2,002
+1,750
| +694% | +$2.62K | ﹤0.01% | 6723 |
|
|
2019
Q2 | $0 | Sell |
252
-17,881
| -99% | – | ﹤0.01% | 7280 |
|
|
2019
Q1 | $47K | Buy |
18,133
+1,263
| +7% | +$3.27K | ﹤0.01% | 4785 |
|
|
2018
Q4 | $27K | Buy |
16,870
+15,005
| +805% | +$24K | ﹤0.01% | 5661 |
|
|
2018
Q3 | $9K | Sell |
1,865
-59,942
| -97% | -$289K | ﹤0.01% | 6311 |
|
|
2018
Q2 | $386K | Sell |
61,807
-6,170
| -9% | -$38.5K | ﹤0.01% | 3710 |
|
|
2018
Q1 | $564K | Sell |
67,977
-857
| -1% | -$7.11K | ﹤0.01% | 3393 |
|
|
2017
Q4 | $702K | Sell |
68,834
-1,628
| -2% | -$16.6K | ﹤0.01% | 3235 |
|
|
2017
Q3 | $645K | Sell |
70,462
-174,516
| -71% | -$1.6M | ﹤0.01% | 3285 |
|
|
2017
Q2 | $1.79M | Buy |
244,978
+136,264
| +125% | +$995K | ﹤0.01% | 2498 |
|
|
2017
Q1 | $783K | Buy |
108,714
+6,276
| +6% | +$45.2K | ﹤0.01% | 3002 |
|
|
2016
Q4 | $599K | Buy |
102,438
+34,279
| +50% | +$200K | ﹤0.01% | 3186 |
|
|
2016
Q3 | $448K | Buy |
68,159
+61,420
| +911% | +$404K | ﹤0.01% | 3213 |
|
|
2016
Q2 | $63K | Buy |
6,739
+1,761
| +35% | +$16.5K | ﹤0.01% | 4502 |
|
|
2016
Q1 | $54K | Buy |
4,978
+1,417
| +40% | +$15.4K | ﹤0.01% | 4657 |
|
|
2015
Q4 | $51K | Sell |
3,561
-760
| -18% | -$10.9K | ﹤0.01% | 4733 |
|
|
2015
Q3 | $91K | Buy |
+4,321
| New | +$91K | ﹤0.01% | 4276 |
|